Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

China flag China · Delayed Price · Currency is CNY
6.71
+0.06 (0.90%)
Mar 10, 2026, 3:00 PM CST
11.28%
Market Cap 4.64B
Revenue (ttm) 2.27B
Net Income (ttm) 222.85M
Shares Out 692.00M
EPS (ttm) 0.32
PE Ratio 21.25
Forward PE n/a
Dividend 0.40 (6.02%)
Ex-Dividend Date Feb 6, 2026
Volume 9,138,501
Average Volume 11,380,257
Open 6.67
Previous Close 6.65
Day's Range 6.65 - 6.73
52-Week Range 5.35 - 8.68
Beta 0.10
RSI 52.04
Earnings Date Apr 25, 2026

About SHA:600351

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China. [Read more]

Sector Healthcare
Founded 1978
Employees 3,611
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600351
Full Company Profile

Financial Performance

In 2024, SHA:600351's revenue was 2.69 billion, a decrease of -7.69% compared to the previous year's 2.91 billion. Earnings were 242.69 million, an increase of 21.60%.

Financial Statements

News

There is no news available yet.